Section of Diabetes and Endocrinology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Texas Children's Hospital, Houston, TX 77030, USA.
J Clin Endocrinol Metab. 2021 Nov 19;106(12):e4822-e4833. doi: 10.1210/clinem/dgab545.
Accumulating evidence indicates that type 2 diabetes (T2D) is phenotypically heterogeneous. Defining and classifying variant forms of T2D are priorities to better understand its pathophysiology and usher clinical practice into an era of "precision diabetes."
We reviewed literature related to heterogeneity of T2D over the past 5 decades and identified a range of phenotypic variants of T2D. Their descriptions expose inadequacies in current classification systems. We attempt to link phenotypically diverse forms to pathophysiology, explore investigative methods that have characterized "atypical" forms of T2D on an etiological basis, and review conceptual frameworks for an improved taxonomy. Finally, we propose future directions to achieve the goal of an etiological classification of T2D.
Differences among ethnic and racial groups were early observations of phenotypic heterogeneity. Investigations that uncover complex interactions of pathophysiologic pathways leading to T2D are supported by epidemiological and clinical differences between the sexes and between adult and youth-onset T2D. Approaches to an etiological classification are illustrated by investigations of atypical forms of T2D, such as monogenic diabetes and syndromes of ketosis-prone diabetes. Conceptual frameworks that accommodate heterogeneity in T2D include an overlap between known diabetes types, a "palette" model integrated with a "threshold hypothesis," and a spectrum model of atypical diabetes.
The heterogeneity of T2D demands an improved, etiological classification scheme. Excellent phenotypic descriptions of emerging syndromes in different populations, continued clinical and molecular investigations of atypical forms of diabetes, and useful conceptual models can be utilized to achieve this important goal.
越来越多的证据表明,2 型糖尿病(T2D)在表型上具有异质性。定义和分类 T2D 的变异形式是优先事项,以便更好地了解其病理生理学,并将临床实践带入“精准糖尿病”时代。
我们回顾了过去 50 年来与 T2D 异质性相关的文献,并确定了一系列 T2D 的表型变异。它们的描述暴露了当前分类系统的不足。我们试图将表型多样化的形式与病理生理学联系起来,探索基于病因学特征“非典型”T2D 形式的研究方法,并回顾用于改进分类法的概念框架。最后,我们提出了实现 T2D 病因分类目标的未来方向。
不同种族和种族群体之间的差异是表型异质性的早期观察结果。流行病学和临床研究表明,性别之间以及成年和青少年发病 T2D 之间存在差异,这支持了导致 T2D 的病理生理途径的复杂相互作用的研究。对非典型 T2D 形式(如单基因糖尿病和酮症倾向糖尿病综合征)的研究说明了病因分类的方法。适应 T2D 异质性的概念框架包括已知糖尿病类型之间的重叠、与“阈值假设”相结合的“调色板”模型以及非典型糖尿病的谱模型。
T2D 的异质性需要改进的病因分类方案。不同人群中新兴综合征的出色表型描述、对非典型糖尿病形式的持续临床和分子研究以及有用的概念模型都可以用于实现这一重要目标。